Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
The Patented Medicine Prices Review Board (PMPRB), Canada’s federal gatekeeper under the Patent Act, sets maximum prices for new patented medicines. Until recently, it did this by comparing a drug’s list price in Canada with that in seven other countries. In 2017, then-federal health minister Jane Philpott chose to try to use the Review Board to drastically reduce Canadian drug prices.
Fifty-two diabetes medications are covered by public or private plans across the country. Ottawa's opening offer to provinces is just 18 Published Oct 23, 2024 • Last updated 6 minutes ago • 4 minute read Medical paraphernalia including test strips to measure blood sugar, needles and vials of insulin belonging to a patient with type 1 diabetics.
Advertisement 1 Three separate federal agencies try to minimize drug profits. A fourth to encourage health readiness won't offset their bad effects • • Article content By Nigel Rawson and John Adams Advertisement 2 Sign In or Create an Account Article content We apologize, but this video has failed to load. Try refreshing your browser, or tap here to see other videos from our team. We apologize, but this video has failed to load.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
